These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
185 related items for PubMed ID: 3458934
1. Time course for the changes of serum lipoproteins and apolipoprotein T concentrations after major surgical trauma in man. Lindh A, Lindholm M, Holmquist L, Carlson LA. JPEN J Parenter Enteral Nutr; 1986; 10(3):265-73. PubMed ID: 3458934 [Abstract] [Full Text] [Related]
2. Serum apolipoproteins and lipoprotein (a) during the first week of life. Strobl W, Widhalm K, Kostner G, Pollak A. Acta Paediatr Scand; 1983 Jul; 72(4):505-9. PubMed ID: 6414239 [Abstract] [Full Text] [Related]
3. Serum lipoprotein and apolipoprotein concentrations in patients with hyperthyroidism and the effect of treatment with carbimazole. Boberg J, Dahlberg PA, Vessby B, Lithell H. Acta Med Scand; 1984 Jul; 215(5):453-9. PubMed ID: 6588732 [Abstract] [Full Text] [Related]
4. Serum apolipoprotein A-I levels: relationship to lipoprotein lipid levels and selected demographic variables. Phillips NR, Havel RJ, Kane JP. Am J Epidemiol; 1982 Aug; 116(2):302-13. PubMed ID: 6810694 [Abstract] [Full Text] [Related]
5. Changes with aging in serum lipoproteins and apolipoprotein C subclasses. Takeuchi N, Matsumoto A, Katayama Y, Arao M, Koga M, Nakao H, Uchida K. Arch Gerontol Geriatr; 1983 Jul; 2(1-2):41-8. PubMed ID: 6578706 [Abstract] [Full Text] [Related]
6. Serum lipoproteins and apolipoproteins A I and A II in male patients with peripheral arterial insufficiency. Angquist KA, Johnson O, Ericsson M, Tollin C. Acta Chir Scand; 1982 Jul; 148(8):675-8. PubMed ID: 6820598 [Abstract] [Full Text] [Related]
7. Serum lipoproteins, apolipoproteins and intravenous fat tolerance in young athletes. Ericsson M, Johnson O, Tollin C, Furberg B, Backman C, Angquist K. Scand J Rehabil Med; 1982 Jul; 14(4):209-12. PubMed ID: 7178868 [Abstract] [Full Text] [Related]
9. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia. Oida K, Nakai T, Tamai T, Kutsumi Y, Kobayashi T, Hayashi T, Yamada S, Takeda R. Artery; 1982 Jul; 10(4):266-85. PubMed ID: 7181672 [Abstract] [Full Text] [Related]
14. Effects of nicotinic acid therapy on plasma lipoproteins and very low density lipoprotein apoprotein C subspecies in hyperlipoproteinemia. Yovos JG, Patel ST, Falko JM, Newman HA, Hill DS. J Clin Endocrinol Metab; 1982 Jun; 54(6):1210-5. PubMed ID: 7076797 [Abstract] [Full Text] [Related]
15. Mechanism of action of a peroxisome proliferator-activated receptor (PPAR)-delta agonist on lipoprotein metabolism in dyslipidemic subjects with central obesity. Ooi EM, Watts GF, Sprecher DL, Chan DC, Barrett PH. J Clin Endocrinol Metab; 2011 Oct; 96(10):E1568-76. PubMed ID: 21816786 [Abstract] [Full Text] [Related]